Diagnostics For All Inc (DFA) is a drug development company that develops and commercializes of new technology and practical diagnostic devices for diagnostic companies. The company uses patterned paper technology to create electrochemical clinical chemistry assays, immunoassays, assays, and molecular diagnostics. Its patterned paper technology delivers diagnostic devices to support animal and human health. DFA operates projects on small farmer support, nucleic acid detection, liver function, child nutrition immunity, among others. The company also develops nucleic acid amplification and immunoassay based paper microfluidic devices. Its small farmer support project develops diagnostics such as milk spoilage and bovine heat detection. DFA is headquartered in Salem, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Diagnostics For All Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Diagnostics For All Inc Company Overview
- Diagnostics For All Inc Company Snapshot
- Diagnostics For All Inc Pipeline Products and Ongoing Clinical Trials Overview
- Diagnostics For All Inc - Pipeline Analysis Overview
- Diagnostics For All Inc - Key Facts
- Diagnostics For All Inc - Major Products and Services
- Diagnostics For All Inc Pipeline Products by Development Stage
- Diagnostics For All Inc Pipeline Products Overview
- Paper-Based Diagnostic Device - Anemia
- Paper-Based Diagnostic Device - Anemia Product Overview
- Paper-Based Diagnostic Device - Hypertensive Disorders
- Paper-Based Diagnostic Device - Hypertensive Disorders Product Overview
- Paper-Based Microfluidic Device - Brucella Abortus
- Paper-Based Microfluidic Device - Brucella Abortus Product Overview
- Paper-Based Microfluidic Device - Ebola
- Paper-Based Microfluidic Device - Ebola Product Overview
- Paper-Based Microfluidic Device - Hepatitis B
- Paper-Based Microfluidic Device - Hepatitis B Product Overview
- Paper-Based Microfluidic Device - Hepatitis C
- Paper-Based Microfluidic Device - Hepatitis C Product Overview
- Paper-Based Microfluidic Device - HIV
- Paper-Based Microfluidic Device - HIV Product Overview
- Paper-Based Microfluidic Test - Syphilis
- Paper-Based Microfluidic Test - Syphilis Product Overview
- Point-Of-Care Diagnostic Assay - Immunity Assessment
- Point-Of-Care Diagnostic Assay - Immunity Assessment Product Overview
- Point-Of-Care Diagnostic Device - Diabetes
- Point-Of-Care Diagnostic Device - Diabetes Product Overview
- Point-Of-Care Diagnostic Device - Malaria
- Point-Of-Care Diagnostic Device - Malaria Product Overview
- Diagnostics For All Inc - Key Competitors
- Diagnostics For All Inc - Key Employees
- Diagnostics For All Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Diagnostics For All Inc, Recent Developments
- Jul 22, 2015: DFA Scientist Receives Seed Grant To Develop Diagnostic Test for Hepatitis B
- Jul 22, 2015: DFA Scientist Receives Seed Grant To Develop Diagnostic Test for Syphilis
- Dec 16, 2014: Governor Patrick, Massachusetts Life Sciences Center Announce $1 Million Grant to Fund Research and Development of Ebola Diagnostic Test
- Sep 19, 2012: BIDMC And DFA Create First Low-Cost, Paper-Based, Point Of Care Liver Function Test
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Diagnostics For All Inc Pipeline Products and Ongoing Clinical Trials Overview
- Diagnostics For All Inc Pipeline Products by Equipment Type
- Diagnostics For All Inc Pipeline Products by Indication
- Diagnostics For All Inc, Key Facts
- Diagnostics For All Inc, Major Products and Services
- Diagnostics For All Inc Number of Pipeline Products by Development Stage
- Diagnostics For All Inc Pipeline Products Summary by Development Stage
- Paper-Based Diagnostic Device - Anemia - Product Status
- Paper-Based Diagnostic Device - Anemia - Product Description
- Paper-Based Diagnostic Device - Hypertensive Disorders - Product Status
- Paper-Based Diagnostic Device - Hypertensive Disorders - Product Description
- Paper-Based Microfluidic Device - Brucella Abortus - Product Status
- Paper-Based Microfluidic Device - Brucella Abortus - Product Description
- Paper-Based Microfluidic Device - Ebola - Product Status
- Paper-Based Microfluidic Device - Ebola - Product Description
- Paper-Based Microfluidic Device - Hepatitis B - Product Status
- Paper-Based Microfluidic Device - Hepatitis B - Product Description
- Paper-Based Microfluidic Device - Hepatitis C - Product Status
- Paper-Based Microfluidic Device - Hepatitis C - Product Description
- Paper-Based Microfluidic Device - HIV - Product Status
- Paper-Based Microfluidic Device - HIV - Product Description
- Paper-Based Microfluidic Test - Syphilis - Product Status
- Paper-Based Microfluidic Test - Syphilis - Product Description
- Point-Of-Care Diagnostic Assay - Immunity Assessment - Product Status
- Point-Of-Care Diagnostic Assay - Immunity Assessment - Product Description
- Point-Of-Care Diagnostic Device - Diabetes - Product Status
- Point-Of-Care Diagnostic Device - Diabetes - Product Description
- Point-Of-Care Diagnostic Device - Malaria - Product Status
- Point-Of-Care Diagnostic Device - Malaria - Product Description
- Diagnostics For All Inc, Key Employees
- Glossary
- Diagnostics For All Inc Pipeline Products by Equipment Type
- Diagnostics For All Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bioscan Inc
- CIS Biotech Inc
- Bio Compression Systems Inc
- ACM Global Central Laboratory Ltd
- AnalizaDx LLC
- HepQuant LLC
